Figure 3 shows several key molecular pathways affected by NAFLD-induced transcriptomic changes in the liver samples from obese patients. The results show the expression of THRB, which encodes TRβ, was significantly decreased in the NAFLD group, which may explain the TH resistance-like manifestation in the clinical findings. Here, THRB is linked to metabolic dysfunction-associated steatotic liver disease.